Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ZYXI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ZYXI

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield 6.38 %
Consecutive Years 0
Forward Annual Dividend 0.15 USD
Consistent Years 0
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date 17.06.2014

Zynex Inc

ZYXI
Current price
2.35 USD +0.06 USD (+2.62%)
Last closed 2.27 USD
ISIN US98986M1036
Sector Healthcare
Industry Medical Distribution
Exchange NASDAQ
Capitalization 67 735 136 USD
Yield for 12 month -77.16 %
1Y
3Y
5Y
10Y
15Y
ZYXI
21.11.2021 - 28.11.2021

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; and M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body; and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, braces for rehabilitation support for knee and wrist, and Dynacomp for cold compression therapy. Further, it develops Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser photoplethysmographic patient monitoring device; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; and fluid monitoring and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Address: 9655 Maroon Circle, Englewood, CO, United States, 80112

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.00 USD

P/E Ratio

Dividend Yield

Financials ZYXI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ZYXI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+192 354 000 USD

Last Year

+184 322 000 USD

Current Quarter

+26 578 000 USD

Last Quarter

+45 974 000 USD

Current Year

+152 925 000 USD

Last Year

+145 956 000 USD

Current Quarter

+18 209 000 USD

Last Quarter

+35 991 000 USD
EBITDA -2 630 000 USD
Operating Margin TTM -49.28 %
Price to Earnings
Return On Assets TTM -4.11 %
PEG Ratio
Return On Equity TTM -27.52 %
Wall Street Target Price 6.00 USD
Revenue TTM 172 400 992 USD
Book Value 0.69 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -42.90 %
Dividend Yield
Gross Profit TTM 134 260 992 USD
Earnings per share -0.24 USD
Diluted Eps TTM -0.24 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -30.00 %
Profit Margin -4.30 %

Stock Valuation ZYXI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 16.61
Enterprise Value Revenue 0.69
Price Sales TTM 0.39
Enterprise Value EBITDA 20.66
Price Book MRQ 3.35

Technical Indicators ZYXI

For 52 Weeks

1.66 USD 10.62 USD
50 Day MA 2.29 USD
Shares Short Prior Month 3 971 213
200 Day MA 5.67 USD
Short Ratio 21.24
Shares Short 3 579 138
Short Percent 25.36 %